Conclusive, the obtained data may prove a valuable resource for further elucidation of non-genomic AhR-signaling in immunomodulation and their potential for targeting in AhR-dependent pathologies, e.g., atherosclerosis and major depressive disorder or diseases associated to a disturbed intestinal immunity. This evidence concerns the gene AHR and major depressive disorder.